Active Pharmaceutical Ingredients (API)

Aesica can support you throughout API process development, optimising or re-designing your route to ensure maximum safety and efficiency ahead of clinical trial and commercial scale manufacture.

Process development with a focus on safety and quality is at the heart of our efficient processes.

  • Our fully-equipped Development Lab allows rapid development of scalable and robust chemical processes utilising technologies such as parallel reactors and Design of Experiments (DoE) methodologies.
  • Our dedicated Kilo Lab operates to cGMP standards and is highly flexible, allowing a range of complex chemistries, making it ideal for the manufacture of batches up to 10kg.
  • Finally, our modern Pilot Plant is able to deliver batch sizes of 10 to 100kg, and has capability to handle both controlled drugs and potent materials.

Aesica’s long tradition of technical expertise in research and development is driven by our team of innovative PhD level chemical and analytical scientists who work alongside dedicated project managers to oversee each project from beginning to end, offering individual support.

We pride ourselves on being flexible and tailoring our services to meet the project requirements. Since we work on a diverse range of compounds, our capabilities are not limited to any particular therapeutic area, which enables us to quickly implement new work programmes to achieve customer objectives.

Our fully-equipped Development Lab allows rapid development of scalable and robust chemical processes utilising technologies such as parallel reactors and Design of Experiments (DoE) methodologies.

Process Research & Development

     

Our dedicated Kilo Lab operates to cGMP standards and is highly flexible, allowing a range of complex chemistries, making it ideal for the manufacture of batches up to 10kg.

Process Research & Development